Evidence map›Paper›PMID 28572487›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2017

Biodistribution and Radiation Dosimetry of

Trine Hjørnevik, Peter W Cipriano, Bin Shen, Jun Hyung Park, Praveen Gulaka, Dawn Holley, Harsh Gandhi, Daehyun Yoon, Erik S Mittra, Greg Zaharchuk and 4 more

2 registry-linked trialsAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03556137 phase1unknown statusnot on this mapstarted 2018, after this paper: background citation

Use of [18F]FTC-146 PET/MRI in the Diagnosis of Chronic Pain

TypeinterventionalSponsorStanford UniversityRan2018 to 2024Enrolled190ConditionsNeuropathic Pain, Nociceptive Pain, Mixed Pain (Nociceptive and Neuropathic), Spinal PainArms[18F]FTC-146
NCT04314856 phase1withdrawnnot on this mapstarted 2021, after this paper: background citation

Sigma-1 Receptors: A Novel Clinical Target in Fragile X Syndrome

TypeinterventionalSponsorGuido A. Davidzon, MD, SMRan2021 to 2022Enrolled0ConditionsFragile X Syndrome (FXS)Arms18F-FTC-146
3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Review
  3. LongitudinalTheranostics · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. RSC medicinal chemistry · 2021
    Review
  17. Article
  18. Exploring 1-adamantanamine as an alternative amine moiety for metabolically labile azepane ring in newly synthesized benzo[Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2020
    Article
  19. Human biodistribution and radiation dosimetry of [European journal of nuclear medicine and molecular imaging · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Trine HjørnevikDepartment of Radiology, Stanford University, Stanford, California.
Peter W CiprianoDepartment of Radiology, Stanford University, Stanford, California.
Bin ShenDepartment of Radiology, Stanford University, Stanford, California.
Jun Hyung ParkDepartment of Radiology, Stanford University, Stanford, California.
Praveen GulakaDepartment of Radiology, Stanford University, Stanford, California.
Dawn HolleyDepartment of Radiology, Stanford University, Stanford, California.
Harsh GandhiDepartment of Radiology, Stanford University, Stanford, California.
Daehyun YoonDepartment of Radiology, Stanford University, Stanford, California.
Erik S MittraDepartment of Radiology, Stanford University, Stanford, California.
Greg ZaharchukDepartment of Radiology, Stanford University, Stanford, California.
Sanjiv S GambhirDepartment of Radiology, Stanford University, Stanford, California.
Christopher R McCurdyDepartment of Medicinal Chemistry, University of Florida, Gainesville, Florida; and.
Frederick T ChinDepartment of Radiology, Stanford University, Stanford, California chinf@stanford.edu biswal@stanford.edu.
Sandip BiswalDepartment of Radiology, Stanford University, Stanford, California chinf@stanford.edu biswal@stanford.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study was to assess safety, biodistribution, and radiation dosimetry in humans for the highly selective σ-1 receptor PET agent

Indexed as

AdultAzepinesBenzothiazolesFemaleHealthy VolunteersHumansIsotope LabelingMagnetic Resonance ImagingMaleMultimodal ImagingRadiometryRadiopharmaceuticalsReceptors, sigmaSigma-1 ReceptorTissue DistributionWhole Body Imaging6-(3-fluoropropyl)-3-(2-(azepan-1-yl)ethyl)benzo(d)thiazol-2(3H)-oneAzepinesBenzothiazolesRadiopharmaceuticalsReceptors, sigmaSigma-1 Receptorbiodistributionfirst-in-humanPETradiation dosimetrysigma-1 receptor

Identifiers

PMID28572487
PMCPMC6944163

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.